Congenital pulmonary airway malformation, or CPAM, is an uncommon developmental abnormality in which a section of fetal lung tissue grows into a mass of cysts or solid tissue instead of forming normal airways and air sacs. It occurs in roughly 1 to 2 out of every 10,000 live births, though improving prenatal ultrasound has made detection more frequent in recent years.1PubMed Central. Prenatal diagnostic accuracy and epidemiology of congenital lung malformations: A retrospective review of cases in a tertiary referral center in northern Finland in 2010-2020 Most CPAMs are picked up on a routine mid-pregnancy ultrasound, which can be alarming for parents who had no reason to expect a problem. The outlook, though, is better than the diagnosis initially sounds: the majority of affected babies do well, especially when the lesion is monitored and managed by an experienced team.
What Happens in the Developing Lung
During normal fetal development, the lung goes through a process called branching morphogenesis, where the airway tubes repeatedly divide and branch out to eventually form the millions of tiny air sacs needed for breathing. In CPAM, something goes wrong during that branching process. Instead of normal airways, a cluster of abnormal cysts or solid tissue forms in one region of the lung. The malformation can arise from different points along the airway tree, from the large bronchi near the center of the lung all the way down to the smallest air sacs at the periphery.2Radiology Case Reports. Congenital pulmonary airway malformation (CPAM): A case report and review of the literature
Research into the underlying cause remains early-stage. One study examining type 2 CPAM tissue found that the problem extends beyond the cells lining the airway. The smooth muscle layer surrounding the cysts was significantly thinner than in normal airways, and a layer of structural protein called elastin that normally sits between the airway lining and the muscle was missing entirely.3Scientific Reports. Alteration of cystic airway mesenchyme in congenital pulmonary airway malformation Proteomic work on types 1 and 2 has shown that the cyst-lining cells express markers typical of bronchial tissue, with type 1 lesions also showing some alveolar cell markers, and that each type has a distinct protein profile.4BioMed Central / Orphanet Journal of Rare Diseases. New insights on congenital pulmonary airways malformations revealed by proteomic analyses In short, nobody can yet point to a single gene or environmental trigger. The best current understanding is that CPAM represents a disruption in the normal conversation between the airway lining cells and the surrounding supportive tissue, occurring at various stages and locations of lung growth.
The Five Types
Doctors classify CPAMs using a system developed by pathologist John Stocker, which groups them by where in the airway tree they originate and what the tissue looks like under a microscope. This matters for prognosis and management, so you will likely hear the type number early on if your child is diagnosed.
- Type 0: Arises from the trachea or large bronchi. Extremely rare, accounting for about 1 to 3 percent of cases, and almost always fatal.
- Type 1: The most common form, making up about 60 to 70 percent of cases. Characterized by one or more large cysts (over 3 centimeters). Children with type 1 generally have the best prognosis.
- Type 2: Accounts for roughly 15 to 30 percent of cases and consists of multiple smaller cysts (under 2 centimeters) mixed with solid areas. This type is the one most often seen alongside other birth defects affecting the kidneys, heart, or skeleton.
- Type 3: Uncommon, occurring in about 5 to 10 percent of cases. The lesion tends to be large and looks mostly solid because the cysts are very small. It arises from the most distal parts of the airway.
- Type 4: Makes up about 5 to 15 percent of cases, with large thin-walled cysts arising from the outermost lung tissue. This type has been linked to malignancy.
Types 0 and 4 were added to the classification in 2002; earlier literature sometimes only describes three types, which can be confusing if you are reading older resources.5Radiology Case Reports. Congenital pulmonary airway malformation (CPAM): A case report and review of the literature6Applied Radiology. Congenital Pulmonary Airway Malformation In practice, type 1 is what most families will be dealing with, and the word “favorable” attached to its prognosis is not just a polite euphemism — outcomes genuinely are good for the majority of these children.
How CPAM Is Found Before Birth
Most CPAMs show up on the anatomy scan performed around 18 to 20 weeks of pregnancy. On ultrasound, the malformation typically appears as a bright (echogenic) mass in one lung, sometimes with visible cysts. A study comparing prenatal imaging methods found that fetal ultrasound detected about 83 percent of congenital lung lesions and correctly identified whether a lesion was a CPAM in roughly 75 percent of cases.7Archives of Disease in Childhood. Diagnostic accuracy of imaging studies in congenital lung malformations When a lesion is found, fetal MRI is sometimes added. MRI is particularly useful for spotting a systemic feeding vessel, an abnormal artery from the body’s main circulation that feeds the lung mass. That detail matters because it changes the diagnosis to a related condition called bronchopulmonary sequestration, or a hybrid of the two.
After the lesion is identified, doctors calculate something called the CPAM volume ratio, or CVR, which compares the size of the mass to the size of the baby’s head. This ratio is the main tool for predicting how much trouble the mass may cause before delivery. A CVR above 1.6 is associated with a high risk of fetal hydrops, a dangerous condition in which fluid accumulates in the baby’s tissues and body cavities.8PubMed Central. Treatment of congenital pulmonary airway malformation with rare high cystic volume ratio: A case report and literature review A meta-analysis of the CVR measurement found it has strong overall accuracy for predicting hydrops, with pooled sensitivity around 86 percent and specificity around 90 percent.9PubMed Central. Diagnostic value of congenital pulmonary airway malformation volume ratio for fetal hydrops due to congenital lung malformations: a systematic review and meta-analysis MRI-based volume measurements can add further predictive power; one study found that a lung mass volume ratio above 2.0 on MRI predicted worse outcomes with 83 percent sensitivity and 99 percent specificity.10PubMed. Fetal MRI lung volumes are predictive of perinatal outcomes in fetuses with congenital lung masses
It is worth knowing that many CPAMs actually shrink on their own as the pregnancy progresses. Parents often hear dire-sounding language at the initial diagnosis, only to see the mass become less prominent on follow-up scans. This spontaneous regression does not mean the malformation disappears. Residual tissue is almost always still present at birth and will need postnatal imaging, usually a CT scan, to get a clearer picture.
When Intervention Happens Before Birth
The vast majority of CPAMs do not require any treatment during pregnancy. Fetal intervention is reserved for the small subset of cases with a high CVR and signs of developing or established hydrops, because untreated hydrops can be fatal. There are two main approaches, and which one is used depends on whether the lesion is predominantly solid (microcystic) or has one or more large cysts (macrocystic).
For microcystic CPAMs with hydrops, prenatal corticosteroids are the first-line treatment. A course of betamethasone given between roughly 19 and 30 weeks has been shown to shrink the mass and resolve hydrops in a high proportion of cases. One systematic review reported that hydrops resolved in about 86 percent of treated fetuses, with the mass shrinking over an average of about four weeks.11American Journal of Obstetrics & Gynecology. Systematic review of the efficacy of antenatal steroids in the management of high-risk microcystic CPAM An integrative review found a somewhat lower but still encouraging hydrops resolution rate of about 70 percent after a single steroid cycle, with overall survival around 84 percent.12PubMed Central. Use of Corticosteroids in Prenatal Treatment of Congenital Pulmonary Adenomatoid Malformation: Integrative Review The slight variation between studies reflects differences in patient selection and timing, but the overall message is consistent: steroids are effective for many high-risk microcystic lesions.
For macrocystic CPAMs, where a single large fluid-filled cyst is compressing the heart and great vessels, the preferred intervention is thoracoamniotic shunting. A small catheter is inserted through the fetal chest wall under ultrasound guidance, draining the cyst fluid into the amniotic space. A case series from two German centers reported that after shunt placement at an average of about 25 weeks, hydrops resolved and the lesion regressed in 96 percent of fetuses, all 25 babies were born alive, and 92 percent survived the newborn period.13PubMed Central. Fetal thoracoamniotic shunting for severe macrocystic congenital pulmonary airway malformation with the Somatex intrauterine shunt: intrauterine course and postnatal outcome Long-term follow-up of shunted children is reassuring too: perinatal survival is high and lasting outcomes are generally excellent, though most children do end up with a mild degree of chest wall asymmetry from the shunt.14PubMed. The long-term outcome following thoraco-amniotic shunting for congenital lung malformations
After Birth and the Imaging Puzzle
At delivery, CPAMs cover a wide spectrum. Some babies are in immediate respiratory distress and need urgent intervention, but a study tracking 35 infants with prenatally diagnosed CPAM found that only about 29 percent had symptoms in the newborn period.15PubMed. Conservative post-natal management of antenatally diagnosed congenital pulmonary airway malformations The remainder appeared perfectly well. For those asymptomatic babies, the standard next step is a postnatal CT scan with contrast, usually performed in the first few months of life. CT gives a far more detailed picture of the lesion’s size, location, and blood supply than ultrasound can, and it is considered the gold standard for surgical planning.16SpringerLink / Pediatr Radiol. Fetal imaging of congenital lung lesions with postnatal correlation
One complication that trips up families and even doctors is that a prenatal ultrasound diagnosis of “CPAM” sometimes turns out to be something else once pathology is available after surgery. Hybrid lesions combining features of CPAM and bronchopulmonary sequestration are more common than once thought, and clinical imaging alone cannot always distinguish between different congenital lung malformations.17PubMed Central. A hybrid lesion of intralobar sequestration with mixed features of CPAM type I and type II unmasked following SARS-CoV-2 infection: Case report and literature review If your child’s diagnosis changes after surgery, that does not mean anyone made an error; it reflects the inherent limitations of imaging for these overlapping conditions.
The Biggest Debate in CPAM Care
When a CPAM causes symptoms after birth, whether breathing problems in a newborn or recurrent lung infections in a toddler, surgery is straightforward and uncontroversial. The real argument is about the baby who is completely fine. Should an asymptomatic CPAM be removed electively, or can the family safely wait and see?
Surgeons have historically leaned toward elective removal, and a systematic review and meta-analysis concluded that elective resection of asymptomatic lesions is safe and prevents the risk of symptoms developing later, which could make eventual surgery more complicated.18PubMed. Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis A study specifically examining the effect of preoperative infection found that children who had already experienced a lung infection before their CPAM surgery had worse outcomes and more complications, reinforcing the logic of getting ahead of trouble.19PubMed Central. Impact of pulmonary infection on thoracoscopic surgery outcomes in children with CPAM: a retrospective study
On the other side, emerging evidence supports watchful waiting for asymptomatic cases, particularly since the risks being prevented (infection, malignancy) are relatively low in absolute terms.20PubMed. The safety of conservative management of asymptomatic congenital pulmonary airway malformations (CPAMs) in children: A systematic review A conservative approach, with regular imaging and clinical follow-up, has been shown to be safe for asymptomatic infants without a significant increase in late complications.21PubMed. Conservative post-natal management of antenatally diagnosed congenital pulmonary airway malformations The reality is that different institutions have different protocols, and individual factors like the size and type of the lesion, the family’s comfort level, and the surgeon’s experience all factor into the decision.22PubMed Central. Rising detection of congenital pulmonary airway malformations and a pragmatic institutional algorithm: a four-patient thoracoscopic case series Parents navigating this decision should expect genuine uncertainty rather than a single correct answer, and should not feel pressured by either camp into a choice that does not fit their circumstances.
How Surgery Is Done
When resection is performed, the standard operation is a lobectomy, removing the entire lobe of the lung that contains the malformation. In some cases, a more limited segmentectomy is possible. Two surgical approaches exist: traditional open surgery through a chest incision (thoracotomy) and minimally invasive surgery using a camera and small instruments through tiny incisions (thoracoscopy).
A propensity-matched study comparing the two found no significant difference in 30-day mortality, readmission rates, or complications, but thoracoscopic surgery was associated with a shorter hospital stay.23PubMed Central. Short-term outcomes of thoracoscopic versus open lobectomy for congenital lung malformations A separate decade-long study in neonates confirmed the expected trade-off: the thoracoscopic approach had much smaller incisions and less blood loss, but operating time was significantly longer.24PubMed Central. Thoracoscopic versus open resection for symptomatic congenital pulmonary airway malformations in neonates: a decade-long retrospective study On the cost side, a nationwide analysis found that thoracoscopic resection was associated with lower total hospital costs and lower readmission costs compared to open thoracotomy.25PubMed. Nationwide Outcomes After Thoracoscopic Versus Open Resection of Congenital Pulmonary Airway Malformations in Newborns A cross-sectional analysis echoed these findings, reporting a mean total cost of about $75,000 for thoracoscopy versus about $82,000 for the open approach, along with a shorter stay of roughly 3 days versus 4.5 days.26Journal of Pediatric Surgery Open. Open versus thoracoscopic approach in the surgical treatment of congenital pulmonary airway malformations: A retrospective cross-sectional analysis and review
Not every baby is a candidate for the thoracoscopic approach. Very large lesions, hemodynamic instability, or a surgeon’s individual expertise may favor the open route. Outcomes are good with either approach, so the choice is less about which is “better” and more about which is best suited to a particular child.
The Malignancy Question
One of the arguments in favor of removing asymptomatic CPAMs is a small but real association with malignancy. The tumors linked to CPAM include mucinous adenocarcinoma of the lung, pleuropulmonary blastoma, and rhabdomyosarcoma.27PubMed Central. Case of mucinous adenocarcinoma of the lung associated with congenital pulmonary airway malformation in a neonate Pleuropulmonary blastoma was once considered the most common CPAM-associated malignancy, but more recent pathology work has reclassified it as a distinct disease that simply looks similar on imaging.28The Annals of Thoracic Surgery Short Reports. Incidental Papillary Adenocarcinoma Arising in a Type I Congenital Pulmonary Airway Malformation
The connection between CPAM and mucinous adenocarcinoma has become more concrete in recent years thanks to genetic studies. A series of neonatal cases found that mucinous adenocarcinoma arising in type 1 CPAM carried somatic KRAS mutations, and all three children were disease-free after surgery alone, without chemotherapy, at follow-ups ranging from 8 months to 6 years.29PubMed. Neonatal congenital pulmonary airway malformation associated with mucinous adenocarcinoma and KRAS mutations A larger study sequenced 61 mucinous cell clusters from CPAM tissue and found KRAS mutations in every single one. The same mutation was also present in the surrounding non-mucinous tissue, and even in some CPAMs that did not yet have visible mucinous clusters, 68 percent still carried a KRAS mutation. The researchers concluded that type 1 and type 3 CPAMs are likely driven by mosaic KRAS mutations arising early in lung development, placing them within a broader family of conditions caused by somatic genetic mosaicism.30PubMed Central. Defining the Spatial Landscape of KRAS Mutated Congenital Pulmonary Airway Malformations: A Distinct Entity with a Spectrum of Histopathologic Features
This is a genuinely interesting finding, but it needs context. The overwhelming majority of CPAM-associated mucinous adenocarcinomas reported in the literature have excellent outcomes when caught early and treated with lobectomy alone. The absolute risk of malignant transformation in any individual CPAM remains low. For families facing the surgery-versus-observation decision, the cancer risk adds a data point, but it is not so large that it should override all other considerations.
Long-Term Lung Function After Surgery
A common fear for parents is whether their child will have permanently reduced lung capacity after losing a lobe. The evidence on this is reassuring. A study testing lung function one year after surgery found that about half of the infants had results in the normal range, and there was no significant difference between children who had an entire lobe removed and those who had a more limited segmentectomy.31PubMed Central. Prognosis of infants with congenital pulmonary airway malformations after surgery: a short and mid-term evaluation Crucially, a prospective study looking at whether earlier surgery leads to better lung function found no correlation between the age at lobectomy and key measures of lung volume or airway function. There was a trend suggesting that children who had surgery later might have slightly lower peak exercise capacity, but the finding did not reach statistical significance.32PubMed. Does earlier lobectomy result in better long-term pulmonary function in children with congenital lung anomalies? A prospective study
The likely explanation is compensatory lung growth. When a lobe is removed in infancy or early childhood, the remaining lung tissue can expand and grow to partially make up the difference. This capacity diminishes with age, which is one reason some surgeons favor operating in the first year of life if resection is planned. Most children go on to live fully active lives, participate in sports, and have no functional limitations. A case report on a young adult who had undergone lobectomy for CPAM found that adding aerobic training to a resistance program improved cardiovascular efficiency and respiratory quality-of-life scores, suggesting that even adults after lobectomy have room for meaningful fitness gains.33Elsevier / Respir Med. Addition of once-weekly aerobic training to ongoing resistance training in a patient with prior lobectomy for congenital pulmonary airway malformation: A case report
Rising Detection and What It Means for Families
Prenatal detection of congenital lung malformations has been climbing. A nationwide study from Colombia found an annual increase of about 2.2 percent in the encounter-based prevalence of congenital pulmonary malformations, almost certainly driven by better imaging and wider access to prenatal care rather than a true rise in the number of affected babies.34PubMed. Population-Based Epidemiology of Congenital Pulmonary Malformations in Early Infancy: A Nationwide Study From Colombia The Finnish data placed the specific prevalence of CPAM at about 1.7 per 10,000 live births.35PubMed Central. Prenatal diagnostic accuracy and epidemiology of congenital lung malformations: A retrospective review of cases in a tertiary referral center in northern Finland in 2010-2020 More detection means more families finding themselves in a fetal medicine clinic unexpectedly, often Googling “CPAM” in a state of shock.
The psychological dimension of a CPAM diagnosis is underappreciated. A study registered with the UK Health Research Authority explored parents’ experiences and highlighted that the core challenge is sustained uncertainty. The diagnosis can arrive at the 20-week scan, but the actual clinical significance of the finding may not become clear until after birth, or even later. Doctors themselves often cannot predict how a given lesion will behave. When the baby is born healthy and the lesion is asymptomatic, the family then faces the watch-and-wait versus surgery conversation, where two reasonable options compete and neither can guarantee a worry-free outcome.36Health Research Authority. Parental Experience of Uncertainty in the Context of the Diagnosis and Management of Congenital Pulmonary Airway Malformation (CPAM) Connecting with other CPAM families through support communities can help, especially in the months between the prenatal scan and the eventual decision about management.
Type 2 CPAM and Associated Anomalies
If there is one type that deserves separate discussion, it is type 2. Unlike types 1, 3, and 4, type 2 CPAM frequently shows up alongside other structural birth defects, most commonly involving the kidneys, heart, and skeleton.37Applied Radiology. Congenital Pulmonary Airway Malformation This does not mean every baby with type 2 will have additional problems, but it does mean the medical team will usually perform a thorough evaluation of other organ systems once a type 2 lesion is identified. The prognosis for type 2 depends heavily on the nature and severity of any associated anomalies rather than on the lung lesion itself, which can sometimes be relatively straightforward to manage once the broader picture is clear.
This stands in contrast to type 1, where the lung lesion is typically the only issue, and to type 4, where the primary concern beyond the lesion itself is the association with malignancy rather than other structural anomalies. Understanding which type your child has is not just academic bookkeeping; it shapes what additional testing the medical team recommends and what the long-term monitoring schedule looks like.